Data as of Q4 2025 (Dec 31, 2025)

Velan Capital Investment Management LP

โ€ขCIK: 1848809โ€ขFiling: Q4 2025

**Velan Capital Investment Management LP** manages $172M across a concentrated portfolio of 46 positions. The fund exhibits significant conviction in select names, with PRAX anchoring the top holding at $29.7M. Further notable allocations include CDTX at $23.9M and TARA at $15.1M, indicating a focused, high-conviction approach to generating alpha. This structure suggests an active, bottom-up investment mandate targeting specific sector opportunities.

Total AUM
$171.9M
+ $482.0K in options
QoQ Performance
+61.5%
Positions
45
+ 1 option
Top 10 Concentration
71.0%
Latest Filing
Q4 2025

Top Holdings Allocation

PRAX
CDTX
TARA
AXD2
MPLT
ABVX
EVMN
PRAX17.2%
CDTX13.9%
TARA8.8%
AXD26.6%
MPLT5.3%
ABVX5.2%
EVMN5.0%
MLYS3.2%

๐Ÿ“ˆ Biggest Buys

MPLT
MAPLIGHT THERAPEUTICS INC
NEW
5.3% of portfolio
EVMN
EVOMMUNE INC
NEW
5.0% of portfolio
ESPR
ESPERION THERAPEUTICS INC NE
NEW
2.6% of portfolio
VRCA
VERRICA PHARMACEUTICALS INC
NEW
2.3% of portfolio
TARA
PROTARA THERAPEUTICS INC
+32.5%
8.8% of portfolio

๐Ÿ“‰ Biggest Sells

PRAX
PRAXIS PRECISION MEDICINES I
-24.1%
17.2% of portfolio
MLYS
MINERALYS THERAPEUTICS INC
-14.0%
3.2% of portfolio
CRBP
CORBUS PHARMACEUTICALS HLDGS
-78.7%
0.1% of portfolio
REPL
REPLIMUNE GROUP INC
-25.0%
0.1% of portfolio
PYXS
PYXIS ONCOLOGY INC
-27.3%
0.0% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

โ€”
ZOOZ PWR LTD
SOLD
$4.3M
ALMS
ALUMIS INC
SOLD
$3.8M
โ€”
SUTRO BIOPHARMA INC
SOLD
$2.7M
QURE
UNIQURE NV
SOLD
$1.9M
TELA
TELA BIO INC
SOLD
$1.1M
+7 more exited positions

Changes from Q3 2025

NEW9 new positions
โ†‘5 increased
โ†“5 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023